Home › Type 2 Diabetes › NCT07868250
KPSC MNT Pilot RCT
KPSC Diabetes Medical Nutrition Therapy (MNT) Pilot Randomized Controlled Trial
Who can join
Ages 18 to 75 · All sexes
Full eligibility criteria
Inclusion Criteria: * Kaiser Permanente Southern California member * Type 2 diabetes diagnosis (ICD-10 codes E11. (all subcodes for type 2 diabetes)) * Ages 18-75 (Age calculated as of the date the eligibility list is generated. Include patients whose age is ≥18 and ≤75 on that date) * Glycated hemoglobin (A1c) between 8-13 (Most recent hemoglobin A1c value within the past 6 months is ≥8% and ≤13% as of the date the eligibility list is generated) * Actively seeing a care manager (Have an upcoming appointment with a Care Manager) Exclusion Criteria: * Kidney disease stage 4-5 (ICD-10 codes: N18.4 (CKD stage 4), N18.5 (CKD stage 5) within last 6 months) * Current dialysis (Procedure codes: CPT 90935, 90937, 90945, 90947, 90999; OR encounter with dialysis service in last 6 months) * Active cancer treatment (ICD-10 codes for cancer (C00-C97) combined with recent treatment (chemotherapy, radiation, immunotherapy) within last 6 months) * Pregnancy (ICD-10 codes O00-O9A, positive pregnancy test labs, or encounters with OB/GYN codes indicating pregnancy in last 9 months) * Diagnosed eating disorders (ICD-10 codes: F50.\* (all eating disorder subcodes). within past 36 months) * Currently in palliative care/hospice (Encounter type or service codes for hospice or palliative care in the past 6 months) * Currently receiving Nutrition Support (Orders for enteral or parenteral nutrition (EN/PN) or dietitian notes indicating ongoing nutrition support in the past 6 months: ID codes: 670795, 520142, 525183, 534927)
About the study
The purpose of this pilot randomized trial is to evaluate the implementation and effectiveness of a Diabetes Medical Nutrition Therapy (DM MNT) program for adults with type 2 diabetes and poor glycemic control receiving care in a large integrated health system. The study will assess implementation outcomes using the RE-AIM framework, as well as changes in glycemic control and other clinical outcomes, to inform potential broader implementation of MNT within routine diabetes care.
What is being tested
- Diabetes Medical Nutrition Therapy (DM MNT) Pilot (behavioral)
Sponsor: Kaiser Permanente · Participants: 600 · Started: Jun 17, 2026
Contact the study team
- Taynara Formagini, PhD · Phone: 626-564-3427
Official record on ClinicalTrials.gov — NCT07868250
Locations in the U.S.
| California | Kaiser Permanente San Bernardino County Medical Center, Fontana |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.